IP Library Granted Patent US 11,471,051
Granted Patent B2
US 11,471,051 · App. 16/889,438 · Granted Oct 18, 2022

Ultraviolet cardiac monitoring and analysis

Inventors: David E. Albert (Oklahoma City, OK); Bruce Satchwell (Gold Coast, AU)
Assignee: AliveCor, Inc.
A61B5/0006A61B5/0022A61B5/282A61B5/6842A61B5/742A61B2560/0431A61B2562/16
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,471,051
App. No.
16/889,438
Granted
Oct 18, 2022
Kind
B2
Abstract

A mobile electrocardiogram (ECG) device is described, comprising an electrode assembly comprising electrodes, wherein the electrode assembly senses heart-related signals when in contact with a body of a user, and produces electrical signals representing the sensed heart-related signals. The mobile ECG device further comprises a converter assembly electrically connected to the electrode assembly, configured to convert the electrical signals to a modulated signal, wherein the modulated signal carries the electrical signals representing the sensed heart-related signals. The mobile ECG device further comprises a transmitter that transmits the modulated signal wirelessly to a computing device. The mobile ECG device further comprises a light-emitting device to facilitate an optimal placement of the electrode on the body of the user. The mobile ECG device further comprises a housing containing the electrode assembly, the converter assembly, the transmitter, and the light-emitting device.

Claims (32)

1. A mobile electrocardiogram (ECG) device comprising:

an electrode assembly comprising electrodes, wherein the electrode assembly senses heart-related signals when in contact with a body of a user, and produces electrical signals representing the sensed heart-related signals;

a converter assembly electrically connected to the electrode assembly, configured to convert the electrical signals to a modulated signal, wherein the modulated signal carries the electrical signals representing the sensed heart-related signals;

a transmitter that transmits the modulated signal wirelessly to a computing device;

a light-emitting device to provide ultra-violet (UV) light to illuminate a location on the body of the user where an electrode of the electrode assembly is to be placed; and

a cylindrical housing containing the electrode assembly, the converter assembly, the transmitter, and the light-emitting device, and wherein a first electrode of the electrode assembly forms a ring that covers one end of the cylindrical housing, the first electrode comprising an opening through which the light-emitting device provides the UV light.

2. The mobile ECG device of claim 1 , wherein the location on the body of the user corresponds to a precordial lead location on the body of the user.

3. The mobile ECG device of claim 1 , wherein the location on the body of the user corresponds to an invisible marking on the body of the user.

4. The mobile ECG device of claim 3 , wherein the invisible marking comprises a tattoo of invisible ink.

5. The mobile ECG device of claim 3 , wherein the invisible marking comprises a temporary marking of invisible ink.

6. The mobile ECG device of claim 1 , wherein the housing is a penlight form factor.

7. The mobile ECG device of claim 1 , wherein the housing comprises a first male or female connector to snap-fit couple to a corresponding second male or female connector on a removable electrode.

8. A mobile electrocardiogram (ECG) system comprising:

a penlight form factor, wherein the penlight form factor houses:

an electrode assembly comprising electrodes positioned on an exterior surface of the penlight form factor, wherein the electrode assembly senses heart-related signals when in contact with a skin of a user, and produces electrical signals representing the sensed heart-related signals;

an ultraviolet (UV) light-emitting device at an end of the penlight form factor, the UV light-emitting device to provide ultra-violet (UV) light to illuminate a location on the body of the user where an electrode of the electrode assembly is to be placed, wherein a first electrode of the electrode assembly forms a ring that covers one end of the penlight form factor, the first electrode comprising an opening through which the UV light-emitting device may provide the UV light;

a converter assembly electrically connected to the electrode assembly, the converter assembly comprising a processor;

a display electrically connected to the converter assembly, the display positioned on the exterior surface of the penlight form factor; and

a memory comprising instructions to cause the processor to process the sensed heart-related signals and display the heart-related signals on the display.

9. The mobile ECG system of claim 8 , wherein the location on the body of the user corresponds to a precordial lead location on the skin of the user.

10. The mobile ECG system of claim 8 , wherein the location on the body of the user corresponds to an invisible marking on the skin of the user.

11. The mobile ECG system of claim 10 , wherein the invisible marking comprises a tattoo of invisible ink.

12. The mobile ECG system of claim 10 , wherein the invisible marking comprises a temporary marking of invisible ink.

13. The mobile ECG system of claim 8 , the form factor further comprising a reservoir to store conductive gel and a button which when activated, causes an excretion of the conductive gel.

14. A method, comprising:

activating, by a processor, a light-emitting device of a mobile electrocardiogram (ECG) device to illuminate an invisible marking on a body of a user using ultra-violet (UV) light, wherein the mobile ECG device comprises a first electrode that forms an opening through which the UV light may pass from the light-emitting device to the body of the user;

determining where to place the first electrode of the mobile ECG device in view of the invisible marking revealed by the light-emitting device; and

sensing heart-related signals when the electrode is in contact with the body of the user, and producing electrical signals representing the sensed heart-related signals.

15. The method of claim 14 , wherein the invisible marking on the body of the user corresponds to a precordial lead location on the body of the user.

16. The method of claim 14 , wherein the invisible marking comprises a tattoo of invisible ink.

17. The method of claim 14 , wherein the invisible marking comprises a temporary marking of invisible ink.

18. The method of claim 14 , wherein the mobile ECG device comprises a penlight form factor.

Assignments (2)
SECURITY INTEREST Recorded Jun 24, 2026
From: ALIVECOR, INC.
To: SYMBIOTIC CAPITAL AGENCY LLC, AS ADMINISTRATIVE AND COLLATERAL AGENT
Reel/Frame 075813/0343 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 1, 2020
From: ALBERT, DAVID E.; SATCHWELL, BRUCE
To: ALIVECOR, INC.
Reel/Frame 052804/0288 →
Continuity (2)
Provisional Application 62855113 · May 31, 2019
Related Publication 20200375458A1 · Dec 3, 2020